Literature DB >> 20114

Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.

T C Hamilton, M W Parkes.   

Abstract

1-(7-Ethylbenzofuran-2-yl)-2-tert.-butylamino-1-hydroxyethane hydrochloride (bufuralol) is a non-selective beta-adrenoceptor blocking agent which closely resembles propranolol in its properties, including potency. Bufuralol is devoid of alpha-adrenoceptor blocking activity but possesses beta-adrenoceptor agonist activity. beta-Adrenoceptor blocking activity resides mainly in the (-)-isomer though membrane stabilising properties are associated with both optical isomers.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20114

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.

Authors:  G D Johnston; M B Finch; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Kinetics and metabolism of (+)-, (-)- and (+/-)-bufuralol.

Authors:  R J Francis; P B East; J Larman
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Pharmacodynamic and pharmacokinetic studies on bufuralol in man.

Authors:  T H Pringle; R J Francis; P B East; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.